But the UPP remains for Biofinity Energys.

CooperVision recently announced that it would remove three products from its unilateral pricing policy, effective immediately.

The products are the MyDay, clariti 1-day and Biofinity XR toric brands, as well as customer brands where applicable. However, the company is maintaining its UPP for Biofinity Energys.

CooperVision said its UPP was developed "as a short-term program to provide incentives for eye care professionals to invest the time and effort needed to evaluate new contact lens technologies and to educate patients about breakthrough lenses – actions are that beneficial for ECPs and millions of wearers alike."

ECPs accomplished those goals, the company said in a note to practitioners.

"MyDay, clariti 1-day and Biofinity XR toric lenses are now widely available and well established, and practices are versed in their advanced technologies and uses," the company stated. "We believe that UPP has accomplished its purpose with regard to these lenses."

But CooperVision said Biofinity Energys is different. 

"As the first lens of its kind, Biofinity Energys has achieved early success with eye care professionals and wearers," the company said in the note. "We believe that ECPs stand to benefit from building additional familiarity with its breakthrough technology, especially given its relatively short time in the market and still-limited distribution. Our UPP encourages ECPs to continue learning about Biofinity Energys, investing time to educate themselves and wearers, and doing so in an economically-sensible manner."

CooperVision said it will continue to evaluate the effectiveness of the UPP.

The company also addressed Utah's controversial Contact Lens Consumer Protection Act, which prohibits the application of UPP to Utah retailers. 

"This has created a situation in which ECPs in other states, abiding by UPP, may be undercut by Utah-based online contact lens sellers," CooperVision stated. "These pricing inequities reduce the effectiveness of CooperVision’s UPP. The recent federal appeals court ruling upholding Utah’s law contributed to our decision to limit our use of UPP and continue to be selective in adopting or maintaining it."